A synthetic peptide for use as a blocking control in assays to test for specificity of SSX2 IP antibody, Alternative Names: SSX2IP control peptide, SSX2IP antibody Blocking Peptide, Anti-SSX2IP Blocking Peptide, Synovial Sarcoma X Breakpoint 2 Interacting Protein Blocking Peptide, ADIP Blocking Peptide, FLJ10848 Blocking Peptide, KIAA0923 Blocking Peptide, MGC75026 Blocking Peptide, SSX2IP, SSXIP-2, SSXIP 2, SSXIP-2 Blocking Peptide, SSXIP 2 Blocking Peptide
SSX2IP
Reaktivität: Human
Wirt: Synthetic
BP, IHC, WB
Applikationshinweise
Optimal conditions should be determined by the investigator
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
Buffer
PBS
Handhabung
Avoid repeated freeze/thaw cycles.
Lagerung
-20 °C
Informationen zur Lagerung
Store at -20 °C long term.
Target
SSX2IP
(Synovial Sarcoma, X Breakpoint 2 Interacting Protein (SSX2IP))
Hintergrund
SSX2IP belongs to an adhesion system, which plays a role in the organization of homotypic, interneuronal and heterotypic cell-cell adherens junctions (AJs). It may connect the nectin-afadin and E-cadherin-catenin system through alpha-actinin and may be involved in organization of the actin cytoskeleton at AJs through afadin and alpha-actinin.